CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents ($51,253 and $28,237 restricted at December 31, 2019 and June 30, 2020, respectively)	$ 160,419	$ 115,752
Accounts receivable, net	753,065	680,569
Short-term investments ($82,772 and $46,315 restricted at December 31, 2019 and June 30, 2020, respectively)	75,671	98,797
Pharmaceutical inventory	36,694	44,962
Other current assets ($36,215 and $73,905 restricted at December 31, 2019 and June 30, 2020, respectively)	80,375	69,687
Current portion of assets held for sale	1,145,904	663,276
Total Current Assets	2,252,128	1,673,043
Property and equipment, net	141,035	131,712
Long-term investments ($2,307 restricted at December 31, 2019)		2,864
Deferred income taxes	28,519	1,840
Other long-term assets	60,770	58,905
Goodwill	806,421	806,421
Other intangible assets, net	62,330	81,675
Assets held for sale, less current portion		335,713
Total Assets	3,351,203	3,092,173
Current Liabilities:
Accounts payable	99,199	83,790
Accrued liabilities	187,286	191,854
Medical claims payable	112,077	128,114
Other medical liabilities	110,268	92,915
Current debt, finance lease and deferred financing obligations	84,942	3,491
Current portion of liabilities held for sale	504,459	409,983
Total Current Liabilities	1,098,231	910,147
Long-term debt, finance lease and deferred financing obligations	641,950	679,125
Deferred income taxes		1,971
Tax contingencies	11,097	9,453
Deferred credits and other long-term liabilities	56,956	56,393
Liabilities held for sale, less current portion		37,301
Total Liabilities	1,808,234	1,694,390
STOCKHOLDERS' EQUITY
Preferred stock, par value $.01 per share Authorized-10,000 shares at December 31, 2019 and June 30, 2020-Issued and outstanding-none
Common stock, par value $.01 per share: Authorized-100,000 shares at December 31, 2019 and June 30, 2020-Issued and outstanding-54,285 and 24,623 shares at December 31, 2019, respectively, and 54,973 and 25,310 shares at June 30, 2020, respectively	550	543
Other Stockholders' Equity:
Additional paid-in capital	1,429,995	1,386,616
Retained earnings	1,576,549	1,475,207
Accumulated other comprehensive income	602	144
Treasury stock, at cost, 29,662 and 29,662 shares at December 31, 2019 and June 30, 2020, respectively	(1,464,727)	(1,464,727)
Total Stockholders' Equity	1,542,969	1,397,783
Total Liabilities and Stockholders' Equity	$ 3,351,203	$ 3,092,173